Ion Beam Applications SA (OTCMKTS:IOBCF – Get Free Report) saw a large increase in short interest in December. As of December 31st, there was short interest totaling 680 shares, an increase of 53.8% from the December 15th total of 442 shares. Based on an average daily volume of 164 shares, the short-interest ratio is presently 4.1 days. Based on an average daily volume of 164 shares, the short-interest ratio is presently 4.1 days.
Ion Beam Applications Stock Performance
Ion Beam Applications stock opened at $16.06 on Friday. Ion Beam Applications has a 52-week low of $10.15 and a 52-week high of $16.15. The stock’s 50 day moving average price is $14.79 and its two-hundred day moving average price is $13.91.
Ion Beam Applications Company Profile
Ion Beam Applications (OTCMKTS: IOBCF) is a Belgium-based medical technology company specializing in the development and deployment of particle therapy solutions for cancer treatment. Founded in 1986 and headquartered in Louvain-la-Neuve, the company is best known for its Proteus® line of proton therapy systems, which are designed to deliver precise, high-energy particle beams that target tumors while sparing healthy tissue. IBA oversees the full project lifecycle, from system design and manufacturing to installation, commissioning, and ongoing service support.
In addition to its flagship proton therapy business, IBA operates a diversified portfolio of technologies for medical and industrial applications.
Read More
- Five stocks we like better than Ion Beam Applications
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- Do not delete, read immediately
- How a Family Trust May Be Able To Help Preserve Your Wealth
- URGENT: Trump Just Triggered AI’s Biggest Disruption Yet
- Wall Street Alert: Buy AES
Receive News & Ratings for Ion Beam Applications Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ion Beam Applications and related companies with MarketBeat.com's FREE daily email newsletter.
